Abstract

Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy and Safety of Front-Line Venetoclax and Rituximab (VenR) for the Treatment of Young Patients with Chronic Lymphocytic Leukemia and an Unfavorable Biologic Profile. Preliminary Results of the Gimema Study ‘Veritas‘
Francesca Romana Mauro ...
Blood | VOL. 136
Francesca Romana Mauro, et. al.Francesca Romana Mauro ...
05 Nov 2020
Worldwide Examination of Patients with CLL Hospitalized for COVID-19
...
Blood | VOL. 136
, et. al. ...
05 Nov 2020
Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
Mazyar Shadman ...
Blood | VOL. 134
Mazyar Shadman, et. al.Mazyar Shadman ...
13 Nov 2019
Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus
Andrea Visentin ...
Blood | VOL. 136
Andrea Visentin, et. al.Andrea Visentin ...
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Momelotinib for the treatment of myelofibrosis.
Prithviraj Bose
Blood | VOL. -
Prithviraj BosePrithviraj Bose
03 Jul 2024
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.
Samuel C.C Chiang ... Yenan T Bryceson
Blood | VOL. -
Samuel C.C Chiang, et. al.Samuel C.C Chiang ... Yenan T Bryceson
03 Jul 2024
Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications.
Elsa Bernard ... Elli Papaemmanuil
Blood | VOL. -
Elsa Bernard, et. al.Elsa Bernard ... Elli Papaemmanuil
03 Jul 2024
Eltrombopag plus diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial.
Lu Sun ... Yu Hou
Blood | VOL. -
Lu Sun, et. al.Lu Sun ... Yu Hou
03 Jul 2024
View more papers